UPDATED Apr 24, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$409.06 | -0.7% | 38.5% | US$3.0t | US$471.24 | PE36.8x | E12.6% | 0.7% | Software | ||
GOOGL | US$159.13 | 2.4% | 53.4% | US$2.0t | US$166.83 | PE26.8x | E11.9% | n/a | Media | ||
AMZN | US$176.59 | -2.6% | 68.2% | US$1.9t | US$209.96 | PE60.4x | E21.6% | n/a | Retail | ||
META | US$493.50 | -0.1% | 135.7% | US$1.3t | US$541.20 | PE32x | E14.4% | 0.4% | Media | ||
LLY | US$732.20 | -2.5% | 94.6% | US$671.7b | US$813.32 | PE125.9x | E27.2% | 0.7% | Pharmaceuticals & Biotech | ||
2330 | NT$767.00 | -4.6% | 55.4% | NT$20.3t | NT$912.98 | PE23.2x | E16.1% | 1.8% | Semiconductors | ||
AVGO | US$1,256.82 | -2.0% | 104.0% | US$578.9b | US$1,500.96 | PE50.3x | E23.4% | 1.7% | Semiconductors | ||
NOVO B | kr.878.70 | 0.8% | 58.2% | kr.3.9t | kr.904.20 | PE46.8x | E14.7% | 1.1% | Pharmaceuticals & Biotech | ||
JPM | US$193.08 | 7.2% | 42.8% | US$551.8b | US$206.47 | PB1.8x | E-1.5% | 2.4% | Banks | ||
XOM | US$121.05 | 2.0% | 4.9% | US$479.1b | US$129.81 | PE13.3x | E-0.6% | 3.1% | Energy | ||
WMT | US$59.87 | 0.4% | 19.0% | US$476.2b | US$65.08 | PE31.1x | E10.7% | 1.4% | Consumer Retailing | ||
UNH | US$487.30 | 1.7% | 0.9% | US$447.3b | US$567.36 | PE29.2x | E19.6% | 1.5% | Healthcare | ||
700 | HK$339.40 | 11.5% | -1.6% | HK$3.2t | HK$417.66 | PE25.4x | E15.0% | 1.0% | Media | ||
PG | US$162.60 | 3.6% | 5.2% | US$381.2b | US$169.90 | PE25.9x | E7.1% | 2.3% | Household | ||
A005930 | ₩76,500.00 | -3.9% | 18.4% | ₩523.0t | ₩101,991.89 | PE35.9x | E27.4% | 1.9% | Tech | ||
JNJ | US$148.53 | 2.6% | -8.7% | US$360.4b | US$173.60 | PE18.7x | E5.1% | 3.3% | Pharmaceuticals & Biotech | ||
HD | US$333.01 | 0.05% | 15.6% | US$336.0b | US$384.83 | PE21.8x | E4.2% | 2.7% | Retail | ||
MRK | US$127.00 | 1.3% | 12.0% | US$321.4b | US$137.58 | PE881.4x | E25.9% | 2.4% | Pharmaceuticals & Biotech | ||
COST | US$723.89 | 1.2% | 46.3% | US$320.5b | US$776.41 | PE47.3x | E7.5% | 0.6% | Consumer Retailing | ||
ORCL | US$115.34 | -2.8% | 23.1% | US$316.3b | US$137.02 | PE29.8x | E14.7% | 1.4% | Software | ||
BAC | US$38.32 | 8.8% | 34.7% | US$301.9b | US$39.61 | PB1.1x | E6.2% | 2.5% | Banks | ||
CVX | US$163.57 | 4.6% | -1.5% | US$300.8b | US$181.37 | PE14.1x | E2.3% | 4.0% | Energy | ||
ABBV | US$167.80 | 2.2% | 3.7% | US$300.2b | US$184.14 | PE61.6x | E23.4% | 3.7% | Pharmaceuticals & Biotech | ||
600519 | CN¥1,693.04 | 1.3% | -3.7% | CN¥2.1t | CN¥2,154.31 | PE28.5x | E12.8% | 3.0% | Food, Beverage & Tobacco |